UK AD-SMART platform trial speeds Alzheimer disease treatment discovery by testing multiple repurposed drugs at once across NHS sites, aiming to protect memory and quality of life.
|Articles|January 1, 1997
- Psychiatric Times Vol 14 No 1
- Volume 14
- Issue 1
Spring Planting
Spring Planting - Poetry of the Times
Advertisement
For Julianna A. Luntz Van Raan
1950-1998
A morning call wakes me
with the news about Julie:
something hard and fibrous in her leg
growing fast and uncontrolled
that can't be weeded out.
Through my bedroom window
I study winter rye in March
swinging on strong stems.
Down below, dandelions wait
to fill the meadow with stars.
I wish I could plant Julie's leg
in a warm tangle of earth,
turn her face toward the sun
and let her nurse on spring rain
until she flowers in a field,
wild and deep as a dandelion.
Read more
of Dr. Berlin's work.
Articles in this issue
almost 26 years ago
Sunday Paradealmost 30 years ago
Guidelines for Clinicians Working with Gifted, Suicidal Adolescentsalmost 30 years ago
Psychiatric Poweralmost 30 years ago
Sleight of Hand - OriginalAdvertisement
Related to this article
When an antidepressant seems to stop working, the patient’s deterioration is real. The explanation may be less certain.
The evidence points toward an overall protective effect in adult cohorts and no increase in completed suicide in younger populations.
A psychiatry resident and APA Diversity Leadership Fellow explains how social history, open talk about stigma, and bilingual videos can widen access to care.
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
Explore evolving ethical challenges of long-acting injectable antipsychotics, weighing relapse prevention against coercion, stigma, incentives, and racial equity in clinical practice.
Neurocrine launches a phase 2 trial of once-daily NBI-'567, testing a selective muscarinic agonist to boost cognition in mild to moderate Alzheimer disease.
Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.
Advertisement
Advertisement
Trending on Psychiatric Times
1
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
2
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
3
Comparison of Atypical Antipsychotics as Adjunctive Treatments for Major Depressive Disorder
4
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
5